Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1987-09-22
1992-04-14
Draper, Garnette D.
Drug, bio-affecting and body treating compositions
Lymphokine
424 852, 424 854, 424 855, 424 856, 514885, 514889, A61K 3702
Patent
active
051046504
ABSTRACT:
A colony stimulating factor, CSF-1, is a lymphokine useful in overcoming the immunosuppression induced by chemotherapy or resulting from other causes. CSF-1 is obtained in usable amounts by recombinant methods, including cloning and expression of the murine and human DNA sequences encoding this protein.
REFERENCES:
patent: 4230697 (1980-10-01), Nishida et al.
patent: 4275056 (1981-06-01), Takaku et al.
patent: 4342828 (1982-08-01), Takaku et al.
patent: 4482485 (1984-01-01), Funakoshi et al.
patent: 4518584 (1985-05-01), Mark et al.
patent: 4690091 (1987-09-01), Rosenberg
patent: 4808611 (1989-02-01), Cosman
patent: 4847325 (1989-07-01), Shadle et al.
patent: 4879227 (1989-11-01), Clark et al.
Bertelmez et al, J. Cellular Physiology 122, 1985, pp. 370-78.
Vadas et al., 1983, J. Immunol. 130:795-799.
Gough, Oncog. Growth Control, 35-42, ed. by Kahn and Graf. Springer:Berlin, Fed. Republic Ger (1986).
Erickson, K. L., et al., 1982, Cellular Immunology, 72:195-201.
DeMaeyer, E., et al., 1988, Interferons and Other Regulatory Cytokines, Chpt. 8, pp. 154-173.
Cameron et al., 1979 J. Clin. Invest., 63:977-984.
Chong Kong T.
Devlin James J.
Kung Ada H. C.
Ralph Peter
Warren Mary K.
Cetus Corporation
Draper Garnette D.
McGarrigle Philip L.
McLaughlin Jane R.
LandOfFree
Uses of recombinant colony stimulating factor-1 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Uses of recombinant colony stimulating factor-1, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Uses of recombinant colony stimulating factor-1 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2347652